Mibolerone is a potent anabolic steroid which is both higher affinity and more selective for the androgen receptor than metribolone.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Prasterone | The serum concentration of Mibolerone can be increased when it is combined with Prasterone. |
| Dextrose, unspecified form | The serum concentration of Dextrose, unspecified form can be decreased when it is combined with Mibolerone. |
| Propranolol | Mibolerone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy. |
| Flunisolide | The risk or severity of edema formation can be increased when Mibolerone is combined with Flunisolide. |
| Beclomethasone dipropionate | The risk or severity of edema formation can be increased when Mibolerone is combined with Beclomethasone dipropionate. |
| Betamethasone | The risk or severity of edema formation can be increased when Mibolerone is combined with Betamethasone. |
| Fluticasone propionate | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluticasone propionate. |
| Fluocinolone acetonide | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluocinolone acetonide. |
| Triamcinolone | The risk or severity of edema formation can be increased when Mibolerone is combined with Triamcinolone. |
| Prednisone | The risk or severity of edema formation can be increased when Mibolerone is combined with Prednisone. |
| Fludrocortisone | The risk or severity of edema formation can be increased when Mibolerone is combined with Fludrocortisone. |
| Hydrocortisone | The risk or severity of edema formation can be increased when Mibolerone is combined with Hydrocortisone. |
| Prednisolone | The risk or severity of edema formation can be increased when Mibolerone is combined with Prednisolone. |
| Methylprednisolone | The risk or severity of edema formation can be increased when Mibolerone is combined with Methylprednisolone. |
| Trilostane | The risk or severity of edema formation can be increased when Mibolerone is combined with Trilostane. |
| Budesonide | The risk or severity of edema formation can be increased when Mibolerone is combined with Budesonide. |
| Dexamethasone | The risk or severity of edema formation can be increased when Mibolerone is combined with Dexamethasone. |
| Corticotropin | The risk or severity of edema formation can be increased when Mibolerone is combined with Corticotropin. |
| Cortisone acetate | The risk or severity of edema formation can be increased when Mibolerone is combined with Cortisone acetate. |
| Paramethasone | The risk or severity of edema formation can be increased when Mibolerone is combined with Paramethasone. |
| Ciclesonide | The risk or severity of edema formation can be increased when Mibolerone is combined with Ciclesonide. |
| Aldosterone | The risk or severity of edema formation can be increased when Mibolerone is combined with Aldosterone. |
| Fluticasone furoate | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluticasone furoate. |
| Fluprednidene | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluprednidene. |
| Tixocortol | The risk or severity of edema formation can be increased when Mibolerone is combined with Tixocortol. |
| Fluprednisolone | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluprednisolone. |
| Meprednisone | The risk or severity of edema formation can be increased when Mibolerone is combined with Meprednisone. |
| Dexamethasone isonicotinate | The risk or severity of edema formation can be increased when Mibolerone is combined with Dexamethasone isonicotinate. |
| Melengestrol | The risk or severity of edema formation can be increased when Mibolerone is combined with Melengestrol. |
| Deflazacort | The risk or severity of edema formation can be increased when Mibolerone is combined with Deflazacort. |
| Cortivazol | The risk or severity of edema formation can be increased when Mibolerone is combined with Cortivazol. |
| Prednylidene | The risk or severity of edema formation can be increased when Mibolerone is combined with Prednylidene. |
| Fluocortin | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluocortin. |
| Fluperolone | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluperolone. |
| Cloprednol | The risk or severity of edema formation can be increased when Mibolerone is combined with Cloprednol. |
| Fluclorolone | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluclorolone. |
| Fluticasone | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluticasone. |
| Mometasone furoate | The risk or severity of edema formation can be increased when Mibolerone is combined with Mometasone furoate. |
| Hydrocortisone acetate | The risk or severity of edema formation can be increased when Mibolerone is combined with Hydrocortisone acetate. |
| Hydrocortisone cypionate | The risk or severity of edema formation can be increased when Mibolerone is combined with Hydrocortisone cypionate. |
| Hydrocortisone succinate | The risk or severity of edema formation can be increased when Mibolerone is combined with Hydrocortisone succinate. |
| Prednisolone phosphate | The risk or severity of edema formation can be increased when Mibolerone is combined with Prednisolone phosphate. |
| Prednisolone hemisuccinate | The risk or severity of edema formation can be increased when Mibolerone is combined with Prednisolone hemisuccinate. |
| Methylprednisolone hemisuccinate | The risk or severity of edema formation can be increased when Mibolerone is combined with Methylprednisolone hemisuccinate. |
| Prednisone acetate | The risk or severity of edema formation can be increased when Mibolerone is combined with Prednisone acetate. |
| Clocortolone acetate | The risk or severity of edema formation can be increased when Mibolerone is combined with Clocortolone acetate. |
| Melengestrol acetate | The risk or severity of edema formation can be increased when Mibolerone is combined with Melengestrol acetate. |
| Betamethasone phosphate | The risk or severity of edema formation can be increased when Mibolerone is combined with Betamethasone phosphate. |
| Cortisone | The risk or severity of edema formation can be increased when Mibolerone is combined with Cortisone. |
| Clobetasol propionate | The risk or severity of edema formation can be increased when Mibolerone is combined with Clobetasol propionate. |
| Fluocinonide | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluocinonide. |
| Hydrocortisone butyrate | The risk or severity of edema formation can be increased when Mibolerone is combined with Hydrocortisone butyrate. |
| Desoximetasone | The risk or severity of edema formation can be increased when Mibolerone is combined with Desoximetasone. |
| Mometasone | The risk or severity of edema formation can be increased when Mibolerone is combined with Mometasone. |
| Fluocortolone | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluocortolone. |
| Prednisolone acetate | The risk or severity of edema formation can be increased when Mibolerone is combined with Prednisolone acetate. |
| Fluorometholone | The risk or severity of edema formation can be increased when Mibolerone is combined with Fluorometholone. |
| Difluocortolone | The risk or severity of edema formation can be increased when Mibolerone is combined with Difluocortolone. |
| Flumethasone | The risk or severity of edema formation can be increased when Mibolerone is combined with Flumethasone. |
| Methylprednisolone aceponate | The risk or severity of edema formation can be increased when Mibolerone is combined with Methylprednisolone aceponate. |
| Lepirudin | Mibolerone may increase the anticoagulant activities of Lepirudin. |
| Bivalirudin | Mibolerone may increase the anticoagulant activities of Bivalirudin. |
| Alteplase | Mibolerone may increase the anticoagulant activities of Alteplase. |
| Urokinase | Mibolerone may increase the anticoagulant activities of Urokinase. |
| Reteplase | Mibolerone may increase the anticoagulant activities of Reteplase. |
| Anistreplase | Mibolerone may increase the anticoagulant activities of Anistreplase. |
| Tenecteplase | Mibolerone may increase the anticoagulant activities of Tenecteplase. |
| Abciximab | Mibolerone may increase the anticoagulant activities of Abciximab. |
| Drotrecogin alfa | Mibolerone may increase the anticoagulant activities of Drotrecogin alfa. |
| Streptokinase | Mibolerone may increase the anticoagulant activities of Streptokinase. |
| Dicoumarol | Mibolerone may increase the anticoagulant activities of Dicoumarol. |
| Argatroban | Mibolerone may increase the anticoagulant activities of Argatroban. |
| Ardeparin | Mibolerone may increase the anticoagulant activities of Ardeparin. |
| Phenindione | Mibolerone may increase the anticoagulant activities of Phenindione. |
| Fondaparinux | Mibolerone may increase the anticoagulant activities of Fondaparinux. |
| Warfarin | Mibolerone may increase the anticoagulant activities of Warfarin. |
| Pentosan polysulfate | Mibolerone may increase the anticoagulant activities of Pentosan polysulfate. |
| Phenprocoumon | Mibolerone may increase the anticoagulant activities of Phenprocoumon. |
| Dipyridamole | Mibolerone may increase the anticoagulant activities of Dipyridamole. |
| Heparin | Mibolerone may increase the anticoagulant activities of Heparin. |
| Enoxaparin | Mibolerone may increase the anticoagulant activities of Enoxaparin. |
| Epoprostenol | Mibolerone may increase the anticoagulant activities of Epoprostenol. |
| Acenocoumarol | Mibolerone may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Mibolerone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Mibolerone may increase the anticoagulant activities of Coumarin. |
| Ximelagatran | Mibolerone may increase the anticoagulant activities of Ximelagatran. |
| Desmoteplase | Mibolerone may increase the anticoagulant activities of Desmoteplase. |
| Defibrotide | Mibolerone may increase the anticoagulant activities of Defibrotide. |
| Ancrod | Mibolerone may increase the anticoagulant activities of Ancrod. |
| Beraprost | Mibolerone may increase the anticoagulant activities of Beraprost. |
| Prasugrel | Mibolerone may increase the anticoagulant activities of Prasugrel. |
| Rivaroxaban | Mibolerone may increase the anticoagulant activities of Rivaroxaban. |
| Sulodexide | Mibolerone may increase the anticoagulant activities of Sulodexide. |
| Semuloparin | Mibolerone may increase the anticoagulant activities of Semuloparin. |
| Idraparinux | Mibolerone may increase the anticoagulant activities of Idraparinux. |
| Cangrelor | Mibolerone may increase the anticoagulant activities of Cangrelor. |
| Astaxanthin | Mibolerone may increase the anticoagulant activities of Astaxanthin. |
| Apixaban | Mibolerone may increase the anticoagulant activities of Apixaban. |
| Otamixaban | Mibolerone may increase the anticoagulant activities of Otamixaban. |
| Amediplase | Mibolerone may increase the anticoagulant activities of Amediplase. |